CorporateInformation.com
 
Company Search:
Advanced Search
 
Featured Products and Services
 
 
Wright Investors Service Perspectives
 
 
 
     
  The Wright Reports site is no longer hosted or operated by Manta. Please review the following:
1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing.
2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com
3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp
4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later) 		 
     
 
 
 
Alchemia Ltd Company Snapshot
Business Description:
Alchemia Ltd operates in the Commercial physical research sector. Alchemia Limited is a biotechnology company. The Company is engaged in developing human therapeutics-based on its drug discovery, dry targeting and synthesis technologies. The Company has two late stage assets in generic fondaparinux and HA-Irinotecan. Generic Fondaparinux asset is fondaparinux sodium for injection, a generic version of the anti-coagulant drug sold under the brand name Arixtra by GlaxoSmithKline. The Hyaluronic Acid Chemotransport Technology platform (HyACT) utilizes Hyaluronic Acid to improve the delivery of chemotherapeutic agents to cancer cells and boost drug efficacy without increasing adverse side effects. Alchemia Inc. and Alchemia Oncology Pty Ltd are the subsidiaries of the Company.
   
   
 
  Stock Performance Chart for Alchemia Ltd
 
  Stock Data: Recent Stock Performance:
  Current Price (2/3/2012): .33
(Figures in Australian Dollars)
1 Week 0.0%   13 Weeks 13.8%  
4 Weeks 20.0%   52 Weeks -52.5%  
 
Alchemia Ltd Key Data:
  Ticker: ACL Country: AUSTRALIA
  Exchanges: FRA OTC Major Industry: Miscellaneous
    Sub Industry: Medical Services
  2003 Sales N/A
(Year Ending Jan 2004).		 Employees: 20
  Currency: Australian Dollars Market Cap: 63,347,013
  Fiscal Yr Ends: June Shares Outstanding: 191,960,644
  Share Type: Ordinary Closely Held Shares: 30,837,811
 
 
Featured Products and Services
  
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.